Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway (Q36381168)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway |
scientific article |
Statements
1 reference
Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway (English)
1 reference
C S Craft
1 reference
D Romero
1 reference
C P H Vary
1 reference
R C Bergan
1 reference
14 May 2007
1 reference
1 reference
7240-7250
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference